美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Galena Biopharma

0.2620

0.0000

成交量：- -

成交额：- -

市值：1,006.21万

市盈率：-0.11

高：0.2620

开：0.2620

低：0.2620

收：0.2620

52周最高：2.41

52周最低：0.2568

股本：3,840.50万

流通股本：937.02万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.2900

净资产收益率：--

总资产收益率：--

市净率：0.53

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Galena Biopharma

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.galenabiopharma.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Galena Biopharma, Inc.在美国特拉华州于2006年4月3日成立作为淘金制药公司，并2006年11月28日更名为瑞克斯的制药公司。2011年9月26日，公司把名称改为格拉纳生物制药有限公司。格拉纳是一家生物技术公司，致力于发现，开发和商业化创新疗法来满足使用有针对性的生物疗法的主要医疗需求。格拉纳是追求用肽为基础的免疫疗法产品的新的癌症治疗学的发展，包括其主要的候选产品肽类（E75）用于治疗乳腺癌和其他肿瘤。在低到中等HER2阳性乳腺癌患者不符合曲妥珠单抗里，肽类药物是一种肽为基础的免疫疗法旨在降低乳腺癌的复发率。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GALE/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GALE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GALE\",,,,,undefined,":{"symbol":"GALE","market":"US","secType":"STK","nameCN":"Galena Biopharma","latestPrice":0.262,"timestamp":1514581200000,"preClose":0.262,"halted":4,"volume":0,"delay":0,"floatShares":9370232,"shares":38405000,"eps":-2.29,"marketStatus":"退市","change":0,"latestTime":"12-29 16:00:00 EST","open":0.262,"high":0.262,"low":0.262,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.29,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1760688000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.262,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GALE\",,,,,undefined,":{"symbol":"GALE","floatShares":9370232,"roa":"--","roe":"--","lyrEps":0,"shares":38405000,"dividePrice":0,"high":0.262,"amplitude":0,"preClose":0.262,"low":0.262,"week52Low":0.2568,"pbRate":"0.53","week52High":2.41,"institutionHeld":0,"latestPrice":0.262,"eps":-2.29,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.29,"open":0.262},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GALE\",params:#limit:5,,,undefined,":[{"date":"2018-01-02","symbol":"GALE","type":"split","dateTimestamp":1514869200000,"forFactor":30,"toFactor":1},{"date":"2018-01-02","symbol":"GALE","newSymbol":"SLS","type":"symbolChange","dateTimestamp":1514869200000},{"market":"US","date":"2017-11-09","symbol":"GALE","fiscalQuarterEnding":"2017/09","expectedEps":-0.15,"name":null,"time":"","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2017-08-14","symbol":"GALE","fiscalQuarterEnding":"2017/06","expectedEps":-0.15,"name":null,"time":"盘后","type":"earning","dateTimestamp":1502683200000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2017-05-10","symbol":"GALE","fiscalQuarterEnding":"2017/03","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1494388800000,"reportTimeType":"","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GALE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GALE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.galenabiopharma.com","stockEarnings":[{"period":"1week","weight":-0.9667},{"period":"1month","weight":-0.9667},{"period":"3month","weight":-0.9667},{"period":"6month","weight":-0.9667},{"period":"1year","weight":-0.9667},{"period":"ytd","weight":-0.9667}],"compareEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":0.001},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.255},{"period":"1year","weight":0.1345},{"period":"ytd","weight":0.1272}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Galena Biopharma, Inc.在美国特拉华州于2006年4月3日成立作为淘金制药公司，并2006年11月28日更名为瑞克斯的制药公司。2011年9月26日，公司把名称改为格拉纳生物制药有限公司。格拉纳是一家生物技术公司，致力于发现，开发和商业化创新疗法来满足使用有针对性的生物疗法的主要医疗需求。格拉纳是追求用肽为基础的免疫疗法产品的新的癌症治疗学的发展，包括其主要的候选产品肽类（E75）用于治疗乳腺癌和其他肿瘤。在低到中等HER2阳性乳腺癌患者不符合曲妥珠单抗里，肽类药物是一种肽为基础的免疫疗法旨在降低乳腺癌的复发率。","exchange":"NASDAQ","name":"Galena Biopharma","nameEN":"Galena Biopharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GALE\",market:\"US\",,,undefined,":null}}